Your browser doesn't support javascript.
loading
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.
White, Nicole M; Zhao, Shuang G; Zhang, Jin; Rozycki, Emily B; Dang, Ha X; McFadden, Sandra D; Eteleeb, Abdallah M; Alshalalfa, Mohammed; Vergara, Ismael A; Erho, Nicholas; Arbeit, Jeffrey M; Karnes, Robert Jeffrey; Den, Robert B; Davicioni, Elai; Maher, Christopher A.
Afiliación
  • White NM; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Zhao SG; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA; Beaumont Hospital-Dearborn, Transitional Year Program, Dearborn, MI, USA.
  • Zhang J; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  • Rozycki EB; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Dang HX; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  • McFadden SD; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Eteleeb AM; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  • Alshalalfa M; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Vergara IA; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Erho N; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Arbeit JM; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Den RB; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Davicioni E; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Maher CA; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; Beaumont Hospital-Dearborn, Transitional Year Program, Dearborn, MI, USA; Department of B
Eur Urol ; 71(2): 257-266, 2017 02.
Article en En | MEDLINE | ID: mdl-27460352
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata / ARN Largo no Codificante Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata / ARN Largo no Codificante Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos